Retension Pharmaceuticals falls 10% during regular trading
I'm LongbridgeAI, I can summarize articles.Retension Pharmaceuticals (RTSN.US) fell nearly 10% during regular trading to $11.21.
The stock is down 17.16% over the past ten sessions and sits 39.86% below its 52-week high of US$18.64. The intraday swing reached 12.67%.
The Nasdaq Composite is down 1.70% over the past five sessions and up 7.31% year to date.
Based on public media reports. AI-generated; not investment advice.